$89.75
Currently 23 wall-street analysts regularly analyze the financials of Blueprint Medicines Corp on a frequent basis to provide recommendations along with target share price. 23 analysts offering 12-month price forecasts for Blueprint Medicines Corp (BPMC) have a share price target of $126.79. This median of share price forecast represents a 41.27% upside from the latest price of $89.75 as on 06.03.25.
As per the chart shown above, analysts believe that the Blueprint Medicines Corp (BPMC) share price will touch around $126.79 in next 12-months.
Below is a chart showing the percentage difference between Blueprint Medicines Corp's share price and its median forecast price. As on 06.03.25, the difference is -27.77%
Based on 23 analysts tracking and researching Blueprint Medicines Corp (BPMC) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 9 | 9 | 9 |
Outperform | 9 | 8 | 8 |
Hold | 4 | 4 | 4 |
Underperform | 1 | 1 | 1 |
Sell | 1 | 1 | 1 |